Mutation Analysis of NF2 Gene in a Chinese Neurofibromatosis lype 2 Kindred
Jang Bo
Abstract
Jang Bo
Abstract
Objective: To elucidate the molecular mechanism of neurofibromatosis type 2 (NF2) with autosomal dominant inheritance disease in a Chinese kindred. Methods: The entire coding region (from exon 1 through 17) of the NF2 gene was amplified using Polymerase chain reaction (PCR) and evaluated for mutations using direct sequencing of the PCR products. PCR-restriction fragment length posymor-phism (PCR-RFLP) was performed to exclude the possibility of NF2 polymorphism in 100 normal control individuals. Results: The clinical and pathologic features including electron microscope examination established the diagnosis of NF2. A novel point mutation (1446 +1g→a) at the boundary of exon 13 and intron 13 was identified, which leads to an altered splice donor site and aberrant coding DNA sequence. Conclusion:The de novo splice donor point mutation in intron 13 of NF2 gene which causes the production of a substantially truncated protein is related to the tumorigenesis of NF2.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To elucidate the molecular mechanism of neurofibromatosis type 2 (NF2) with autosomal dominant inheritance disease in a Chinese kindred. Methods: The entire coding region (from exon 1 through 17) of the NF2 gene was amplified using Polymerase chain reaction (PCR) and evaluated for mutations using direct sequencing of the PCR products. PCR-restriction fragment length posymor-phism (PCR-RFLP) was performed to exclude the possibility of NF2 polymorphism in 100 normal control individuals. Results: The clinical and pathologic features including electron microscope examination established the diagnosis of NF2. A novel point mutation (1446 +1g→a) at the boundary of exon 13 and intron 13 was identified, which leads to an altered splice donor site and aberrant coding DNA sequence. Conclusion:The de novo splice donor point mutation in intron 13 of NF2 gene which causes the production of a substantially truncated protein is related to the tumorigenesis of NF2.
Key concepts: Exon, Genetics, Neurofibromatosis type 2, Point mutation, Biology, Gene, Intron, Coding region